๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The role of stem cell transplantation in the management of chronic lymphocytic leukaemia

โœ Scribed by Constantine S. Tam; Issa Khouri

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
139 KB
Volume
27
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

โœฆ Synopsis

Abstract

The majority of patients diagnosed with chronic lymphocytic leukaemia (CLL) will ultimately die of their disease. Stem cell transplantation (SCT) remains the only treatment modality capable of cure, but has traditionally been associated with very high morbidity and mortality. We review the results of myeloablative autologous and allogeneic SCT in CLL, discuss the evolution of the new nonโ€myeloablative approaches, and make recommendations for when SCT should be considered in patients with CLL. Copyright ยฉ 2009 John Wiley & Sons, Ltd.

๐Ÿ“œ SIMILAR VOLUMES

The effect of allogeneic stem cell trans
The effect of allogeneic stem cell transplantation on high risk chronic lymphocytic leukaemia: a single centre retrospective analysis
โœ V Vรกlkovรก; J Schwarz; A Vรญtek; M Markovรก; D Pohlreich; K Beneลกovรก; K Michalovรก; ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 279 KB

## Abstract In recent years, many studies have confirmed that allogeneic stem cell transplantation (alloโ€SCT) can provide longโ€term disease control and possible cure in selected patients with chronic lymphocytic leukaemia (CLL), including those with a biologically highly unfavourable risk profile.

Elucidating the role of protein kinase C
Elucidating the role of protein kinase C in chronic lymphocytic leukaemia
โœ Alison M Michie; Rinako Nakagawa ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 134 KB

While advances have been made in the clinical treatment of chronic lymphocytic leukaemia (CLL) in recent years, it is still an incurable disease and therefore the identification of novel drug therapies is of paramount importance. Understanding the molecular mechanisms that govern the survival of CLL

Intensive leukapheresis in the managemen
Intensive leukapheresis in the management of cytopenias in patients with chronic lymphocytic leukaemia (CLL) and lymphocytic lymphoma
โœ Dr. I. A. Cooper; J. C. Ding; P. B. Adams; M. A. Quinn; M. Brettell ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 547 KB

## Abstract The role of leukapheresis was explored in the management of anaemia and thrombocytopenia complicating the accumulation of lymphoid cells in patients with chronic lymphocytic leukaemia and lymphoma. The aim of this study was to determine the efficiency of this procedure in correcting the

B-cell chronic lymphocytic leukaemia: Pr
B-cell chronic lymphocytic leukaemia: Prognostic value of the immunophenotype and the clinico-haematological features
โœ Alberto Orfao; Marcos Gonzalez; J. San Fernando Miguel; Agustin Rios; M. Consuel ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 522 KB

Sixty-two previously untreated patients with B-cell chronic lymphocytic leukaemia were analysed to study the prognostic value of both the immunologic phenotype and the clinicobiologic characteristics. Univariate studies showed that none of the immunological markers analysed, sheep-rosette, mouse-ros